Organization (Other)
ACCESS BUSINESS GROUP LLC
ClinicalTrials.gov lists ACCESS BUSINESS GROUP LLC as lead sponsor of 11 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers ACCESS BUSINESS GROUP LLC: 11 lead-sponsored trials and 1 legal-entity registration.
Disease areas (14)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Death | 2 |
| Infant Death | 2 |
| Malnutrition | 2 |
| Vitamin A Deficiency | 2 |
| Dyslipidemias | 1 |
Showing 5 of 14 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 2 |
| 2010 | 1 |
| 2004 | 2 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Journals published in (26)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The American journal of clinical nutrition | 5 |
| The Journal of nutrition | 5 |
| JAMA | 2 |
| Journal of lipid research | 2 |
| American journal of epidemiology | 1 |
Showing 5 of 26 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 1 | 0 | 2009-01-13 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| VAI | 19 |
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 4 | 2023-08-15 |
Manufacturing and distribution sites (3)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| Access Business Group LLC | Ada, US | FDA, Health Canada | |
| Access Business Group LLC | Ada, US | FDA | |
| Access Business Group LLC | Buena Park, US | FDA |
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| Sinphar Pharmaceutical Co., Ltd | Co sponsors trial with | 1 |
Latest dated events (37)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-05 | FDA inspection | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-09-05 | FDA inspection | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-09-05 | FDA inspection | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2024-06-27 | FDA inspection | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
Showing 5 of 37 events.
Biomarker capability evidence (20)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CRP | Trial sponsor | Named in trial inclusion criteria |
| AGT | Trial sponsor | Named in trial exclusion criteria |
| AGT | Trial sponsor | Named in trial exclusion criteria |
| ATP12A | Trial sponsor | Named in trial exclusion criteria |
| ATP12A | Trial sponsor | Named in trial exclusion criteria |
Showing 5 of 20 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.